$SERA
SERA PROGNOSTICS, INC. Stock $sera

$sera Overview Financials Valuation SEC Filings Company Website

2022 Q2 Form 10-Q Financial Statement

#000153496922000123 Filed on August 10, 2022

Income Statement

Concept	2022 Q2	2022 Q1	2021 Q4
Revenue	$78.00K	$38.00K	$26.00K
YoY Change	290.0%	192.31%	333.33%
Cost Of Revenue	$56.00K	$20.00K	$14.00K
YoY Change	600.0%	300.0%	366.67%
Gross Profit	$22.00K	$18.00K	$12.00K
YoY Change	83.33%	125.0%	300.0%
Gross Profit Margin	28.21%	47.37%	46.15%
Selling, General & Admin	$8.507M	$8.996M	$9.484M
YoY Change	86.19%	147.35%	255.87%
% of Gross Profit	38668.18%	49977.78%	79033.33%
Research & Development	$3.261M	$3.322M	$3.075M
YoY Change	15.47%	38.65%	47.13%
% of Gross Profit	14822.73%	18455.56%	25625.0%
Depreciation & Amortization	$200.0K	$200.0K	$145.0K
YoY Change	0.0%	0.0%	-28.22%
% of Gross Profit	909.09%	1111.11%	1208.33%
Operating Expenses	$11.82M	$12.34M	$12.56M
YoY Change	59.76%	104.34%	164.01%
Operating Profit	-$11.75M	-$12.30M	-$12.55M
YoY Change	59.14%	104.15%	163.93%
Interest Expense	$18.00K	$4.000K	$90.00K
YoY Change	-1000.0%	-98.7%	-116.25%
% of Operating Profit
Other Income/Expense, Net	$244.0K	$96.00K	-$27.00K
YoY Change	-77.24%	-455.56%	-59.7%
Pretax Income	-$11.52M	-$12.21M	-$12.48M
YoY Change	82.65%	91.98%	132.26%
Income Tax
% Of Pretax Income
Net Earnings	-$11.52M	-$12.21M	-$12.48M
YoY Change	82.65%	91.98%	132.26%
Net Earnings / Revenue	-14769.23%	-32126.32%	-48015.38%
Basic Earnings Per Share	-$0.37	-$0.40
Diluted Earnings Per Share	-$0.37	-$0.40	-$409.2K
COMMON SHARES
Basic Shares Outstanding	30.95M shares	30.80M shares
Diluted Shares Outstanding	30.95M shares	30.80M shares

Balance Sheet

Concept	2022 Q2	2022 Q1	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$106.9M	$107.5M	$105.1M
YoY Change	17.68%	79.2%
Cash & Equivalents	$53.89M	$64.10M	$58.93M
Short-Term Investments	$53.02M	$43.47M	$46.18M
Other Short-Term Assets	$1.009M	$1.875M	$1.993M
YoY Change	100.6%	345.37%
Inventory
Prepaid Expenses
Receivables	$73.00K	$39.00K	$27.00K
Other Receivables	$55.00K	$9.000K	$3.116M
Total Short-Term Assets	$108.0M	$109.5M	$110.3M
YoY Change	18.26%	81.11%	702.82%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.197M	$2.913M	$1.773M
YoY Change	267.05%	252.66%	83.73%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$13.68M	$22.34M	$34.85M
YoY Change
Other Assets	$363.0K	$487.0K	$157.0K
YoY Change	-87.16%	-66.94%	60.2%
Total Long-Term Assets	$17.01M	$25.40M	$36.78M
YoY Change	359.77%	1004.61%	3359.83%
TOTAL ASSETS
Total Short-Term Assets	$108.0M	$109.5M	$110.3M
Total Long-Term Assets	$17.01M	$25.40M	$36.78M
Total Assets	$125.1M	$134.9M	$147.0M
YoY Change	31.55%	114.94%	893.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$783.0K	$945.0K	$1.197M
YoY Change	-23.68%	13.99%	171.43%
Accrued Expenses	$2.365M	$2.007M	$2.958M
YoY Change	29.09%	15.21%
Deferred Revenue	$3.102M	$3.112M	$3.116M
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$456.0K	$351.0K	$74.00K
YoY Change	542.25%	-54.53%
Total Short-Term Liabilities	$7.303M	$6.944M	$8.411M
YoY Change	125.96%	85.87%	-25.18%
LONG-TERM LIABILITIES
Long-Term Debt	$848.0K	$718.0K	$54.00K
YoY Change	831.87%	57.11%
Other Long-Term Liabilities			$0.00
YoY Change
Total Long-Term Liabilities	$848.0K	$718.0K	$54.00K
YoY Change	32.11%	-31.74%
TOTAL LIABILITIES
Total Short-Term Liabilities	$7.303M	$6.944M	$8.411M
Total Long-Term Liabilities	$848.0K	$718.0K	$54.00K
Total Liabilities	$8.151M	$7.662M	$8.465M
YoY Change	110.24%	60.03%	-31.35%
SHAREHOLDERS EQUITY
Retained Earnings	-$190.2M	-$178.7M	-$166.5M
YoY Change	31.99%		26.63%
Common Stock	$3.000K	$3.000K	$3.000K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$116.9M	$127.2M	$138.6M
YoY Change
Total Liabilities & Shareholders Equity	$125.1M	$134.9M	$147.0M
YoY Change	31.55%	114.94%	893.71%

Cashflow Statement

Concept	2022 Q2	2022 Q1	2021 Q4
OPERATING ACTIVITIES
Net Income	-$11.52M	-$12.21M	-$12.48M
YoY Change	82.65%	91.98%	132.26%
Depreciation, Depletion And Amortization	$200.0K	$200.0K	$145.0K
YoY Change	0.0%	0.0%	-28.22%
Cash From Operating Activities	-$9.038M	-$9.557M	-$9.152M
YoY Change	44.89%	37.51%	118.69%
INVESTING ACTIVITIES
Capital Expenditures	-$219.0K	$7.000K	-$749.0K
YoY Change	157.65%	-82.93%	1602.27%
Acquisitions
YoY Change
Other Investing Activities	-$990.0K	$14.64M	-$13.68M
YoY Change
Cash From Investing Activities	-$1.209M	$14.63M	-$14.43M
YoY Change	1322.35%	-35792.68%	32700.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	58.00K	$71.00K	37.00K
YoY Change	-99.84%	-99.87%	-104.02%
NET CHANGE
Cash From Operating Activities	-9.038M	-$9.557M	-9.152M
Cash From Investing Activities	-1.209M	$14.63M	-14.43M
Cash From Financing Activities	58.00K	$71.00K	37.00K
Net Change In Cash	-10.19M	$5.148M	-23.55M
YoY Change	-133.04%	-88.92%	357.31%
FREE CASH FLOW
Cash From Operating Activities	-$9.038M	-$9.557M	-$9.152M
Capital Expenditures	-$219.0K	$7.000K	-$749.0K
Free Cash Flow	-$8.819M	-$9.564M	-$8.403M
YoY Change	43.33%	36.8%	102.92%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001534969
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Amendment Flag AmendmentFlag	false
CY2021Q3	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.481000
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent
CY2022Q2	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2021Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#AccruedLiabilitiesAndOtherLiabilities
CY2022Q2	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#AccruedLiabilitiesAndOtherLiabilities
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-40606
	dei	Entity Registrant Name EntityRegistrantName	SERA PROGNOSTICS, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-1911522
	dei	Entity Address Address Line1 EntityAddressAddressLine1	2749 East Parleys Way
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 200
	dei	Entity Address City Or Town EntityAddressCityOrTown	Salt Lake City
	dei	Entity Address State Or Province EntityAddressStateOrProvince	UT
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	84109
	dei	City Area Code CityAreaCode	801
	dei	Local Phone Number LocalPhoneNumber	990-0520
	dei	Security12b Title Security12bTitle	Class A Common Stock, $0.0001 par value per share
	dei	Trading Symbol TradingSymbol	SERA
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	53891000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	58932000	usd
CY2022Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	53021000	usd
CY2021Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	46183000	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	73000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	27000	usd
CY2022Q2	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	55000	usd
CY2021Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	3116000	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1009000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1993000	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	108049000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	110251000	usd
CY2022Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	2967000	usd
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	1773000	usd
CY2022Q2	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	13677000	usd
CY2021Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	34848000	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	363000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	157000	usd
CY2022Q2	us-gaap	Assets Assets	125056000	usd
CY2021Q4	us-gaap	Assets Assets	147029000	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	783000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1197000	usd
CY2022Q2	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	2962000	usd
CY2021Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	3885000	usd
CY2022Q2	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	0	usd
CY2021Q4	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	139000	usd
CY2022Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	456000	usd
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	74000	usd
CY2022Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3102000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3116000	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	7303000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	8411000	usd
CY2022Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	848000	usd
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	54000	usd
CY2022Q2	us-gaap	Liabilities Liabilities	8151000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	8465000	usd
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	3000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	3000	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	307916000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	305212000	usd
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-818000	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-183000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-190196000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-166468000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	116905000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	138564000	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	125056000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	147029000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	78000	usd
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	20000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	116000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	33000	usd
CY2022Q2	sera	Cost Of Revenue Excluding Selling Marketing General And Administrative Expense CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense	56000	usd
CY2021Q2	sera	Cost Of Revenue Excluding Selling Marketing General And Administrative Expense CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense	8000	usd
	sera	Cost Of Revenue Excluding Selling Marketing General And Administrative Expense CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense	76000	usd
	sera	Cost Of Revenue Excluding Selling Marketing General And Administrative Expense CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense	13000	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3261000	usd
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2824000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6583000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5221000	usd
CY2022Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4219000	usd
CY2021Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1740000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	8677000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3090000	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4288000	usd
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2829000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8826000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5116000	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	11824000	usd
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	7401000	usd
	us-gaap	Operating Expenses OperatingExpenses	24162000	usd
	us-gaap	Operating Expenses OperatingExpenses	13440000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-11746000	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-7381000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-24046000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-13407000	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	18000	usd
CY2021Q2	us-gaap	Interest Expense InterestExpense	-2000	usd
	us-gaap	Interest Expense InterestExpense	22000	usd
	us-gaap	Interest Expense InterestExpense	305000	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	244000	usd
CY2021Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1072000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	340000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1046000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-11520000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-6307000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-23728000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-12666000	usd
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.37
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.37
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.17
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.17
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.77
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.77
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-6.70
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-6.70
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30945616	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30945616	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1988886	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1988886	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	138564000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	98000	usd
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30873995	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30873995	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1890908	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1890908	shares
CY2022Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-162000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	0	usd
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-635000	usd
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	0	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-162000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-635000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	usd
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-11682000	usd
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-6307000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-24363000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-12666000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-12666000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1222000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-473000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-12208000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	127203000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	170000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1214000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-162000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-11520000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	116905000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-125570000	usd
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	1071000	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	229000	usd
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	239000	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-6359000	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	-130390000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	35000	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	864000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-6307000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	-135798000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-23728000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	350000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	378000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2436000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1103000	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	9000	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	158000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	1050000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-5000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-9000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	46000	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	34852000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	12000	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-3116000	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	0	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1277000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	309000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-484000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	197000	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-1516000	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-935000	usd
	sera	Increase Decrease In Deferred Rent IncreaseDecreaseInDeferredRent	0	usd
	sera	Increase Decrease In Deferred Rent IncreaseDecreaseInDeferredRent	-61000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-14000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	0	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-18595000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-13188000	usd
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	21217000	usd
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	0	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	226000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	126000	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	16000	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	13425000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-126000	usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	0	usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	1071000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	214000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	264000	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	4494000	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	0	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	3100000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	85000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	34000	usd
	sera	Payments Of Deferred Stock Issuance Costs PaymentsOfDeferredStockIssuanceCosts	0	usd
	sera	Payments Of Deferred Stock Issuance Costs PaymentsOfDeferredStockIssuanceCosts	2133000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	129000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	90632000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-5041000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	77318000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	58932000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13533000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	53891000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	90851000	usd
	us-gaap	Interest Paid Net InterestPaidNet	13000	usd
	us-gaap	Interest Paid Net InterestPaidNet	1270000	usd
	sera	Purchases Of Property And Equipment Included In Accounts Payable And Accrued Liabilities PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities	68000	usd
	sera	Purchases Of Property And Equipment Included In Accounts Payable And Accrued Liabilities PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities	149000	usd
	sera	Senior Convertible Preferred Stock Offering Costs Included In Accounts Payable And Accrued Liabilities SeniorConvertiblePreferredStockOfferingCostsIncludedInAccountsPayableAndAccruedLiabilities	0	usd
	sera	Senior Convertible Preferred Stock Offering Costs Included In Accounts Payable And Accrued Liabilities SeniorConvertiblePreferredStockOfferingCostsIncludedInAccountsPayableAndAccruedLiabilities	80000	usd
	sera	Prepaid And Deferred Offering Costs Reclassified To Senior Convertible Preferred Stock PrepaidAndDeferredOfferingCostsReclassifiedToSeniorConvertiblePreferredStock	26000	usd
	sera	Prepaid And Deferred Offering Costs Reclassified To Senior Convertible Preferred Stock PrepaidAndDeferredOfferingCostsReclassifiedToSeniorConvertiblePreferredStock	0	usd
	sera	Deferred Offering Costs Incurred But Not Yet Paid DeferredOfferingCostsIncurredButNotYetPaid	0	usd
	sera	Deferred Offering Costs Incurred But Not Yet Paid DeferredOfferingCostsIncurredButNotYetPaid	618000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-190200000	usd
CY2022Q2	sera	Cash And Cash Equivalents Debt Securities Available For Sale Fair Value CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue	120600000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the condensed financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the amounts reported in the condensed financial statements and accompanying notes. The Company evaluates these estimates on an ongoing basis. The Company bases these estimates on historical and anticipated results, trends, and various other assumptions that the Company believes are reasonable under the circumstances, including assumptions as to future events. Actual results could differ materially from those estimates.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic and the evolving actions of governments, private sector participants and the public in an effort to contain the spread of the COVID-19 virus and address its impacts have intensified and have had significant direct and indirect effects on businesses and commerce. The extent to which the COVID-19 pandemic may impact the Company’s business, financial condition, cash flows, and results of operations, in particular, will depend on future </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">developments that are uncertain, many of which are outside the Company’s control. Such developments include the availability and effectiveness of actions taken to contain or treat COVID-19, the ultimate geographic spread and duration of the pandemic, the extent and duration of a resurgence of the COVID-19 virus and variant strains thereof, new information concerning the severity of the COVID-19 virus, the effectiveness and intensity of measures to contain the COVID-19 virus and the economic impact of the pandemic and the reactions to it. Such developments, among others, depending on their nature, duration, and intensity, could have a significant adverse effect on the Company’s business, financial condition, cash flows, and results of operations.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no significant estimates contained in the preparation of the Company’s condensed financial statements or impacts to the Company’s condensed financial statements for the three and six months ended June 30, 2022 that were a direct result of the COVID-19 pandemic. The Company is not aware of any specific event or circumstance that would require an update to its estimates, judgments and assumptions or a revision of the carrying value of the Company’s assets or liabilities as of the date of the condensed financial statements.</span></div>
CY2022Q2	sera	Cash And Cash Equivalents Debt Securities Available For Sale Amortized Cost CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost	121407000	usd
CY2022Q2	sera	Cash And Cash Equivalents Debt Securities Available For Sale Accumulated Gross Unrealized Gain Before Tax CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax	11000	usd
CY2022Q2	sera	Cash And Cash Equivalents Debt Securities Available For Sale Accumulated Gross Unrealized Loss Before Tax CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax	829000	usd
CY2022Q2	sera	Cash And Cash Equivalents Debt Securities Available For Sale Fair Value CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue	120589000	usd
CY2021Q4	sera	Cash And Cash Equivalents Debt Securities Available For Sale Amortized Cost CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost	140146000	usd
CY2021Q4	sera	Cash And Cash Equivalents Debt Securities Available For Sale Accumulated Gross Unrealized Gain Before Tax CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax	0	usd
CY2021Q4	sera	Cash And Cash Equivalents Debt Securities Available For Sale Accumulated Gross Unrealized Loss Before Tax CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax	183000	usd
CY2021Q4	sera	Cash And Cash Equivalents Debt Securities Available For Sale Fair Value CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue	139963000	usd
CY2021Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	0	usd
CY2022Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	0	usd
CY2022Q2	us-gaap	Other Than Temporary Impairment Credit Losses Recognized In Earnings Credit Losses On Debt Securities Held OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld	0	usd
CY2021Q4	us-gaap	Other Than Temporary Impairment Credit Losses Recognized In Earnings Credit Losses On Debt Securities Held OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld	0	usd
CY2022Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	53713000	usd
CY2022Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	53021000	usd
CY2022Q2	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	13798000	usd
CY2022Q2	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	13677000	usd
CY2022Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	67511000	usd
CY2022Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	66698000	usd
CY2022Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	8882000	usd
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	7740000	usd
CY2022Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	5915000	usd
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	5967000	usd
CY2022Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	2967000	usd
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	1773000	usd
CY2022Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	200000	usd
CY2021Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	200000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	400000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	400000	usd
CY2022Q2	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	1483000	usd
CY2021Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	2498000	usd
CY2022Q2	us-gaap	Accrued Vacation Current AccruedVacationCurrent	583000	usd
CY2021Q4	us-gaap	Accrued Vacation Current AccruedVacationCurrent	460000	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	299000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	0	usd
CY2022Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	597000	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	927000	usd
CY2022Q2	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	2962000	usd
CY2021Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	3885000	usd
CY2022Q2	us-gaap	Interest Income Other InterestIncomeOther	66000	usd
CY2021Q2	us-gaap	Interest Income Other InterestIncomeOther	18000	usd
	us-gaap	Interest Income Other InterestIncomeOther	144000	usd
	us-gaap	Interest Income Other InterestIncomeOther	21000	usd
CY2022Q2	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	0	usd
CY2021Q2	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	4000	usd
	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	0	usd
	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	-6000	usd
CY2022Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2021Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	1050000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	1050000	usd
CY2022Q2	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	178000	usd
CY2021Q2	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	0	usd
	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	196000	usd
	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	-19000	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	244000	usd
CY2021Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1072000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	340000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1046000	usd
CY2022Q2	sera	Number Of Common Stock Classes Authorized NumberOfCommonStockClassesAuthorized	2	common_stock_class
CY2022Q2	sera	Common Stock Conversion Ratio CommonStockConversionRatio	1
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6287126	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.36
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y9M18D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	20095000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	3087510	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3.29
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	413633	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	7.23
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	217860	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.23
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8743143	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.92
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y2M12D
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	499000	usd
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	8252641	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	3.86
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P8Y1M6D
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	490000	usd
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	3255726	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	2.85
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P6Y6M
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	239000	usd
CY2022Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1214000	usd
CY2021Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	864000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2436000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1103000	usd
CY2022Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	14100000	usd
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y9M18D
CY2022Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	2788484	shares
CY2021Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	2788484	shares
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	230000	usd
CY2022Q2	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	1484000	usd
CY2022Q2	sera	Right Of Use Asset Total RightOfUseAssetTotal	1714000	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	299000	usd
CY2022Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	456000	usd
CY2022Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	848000	usd
CY2022Q2	sera	Lease Liabilities Total LeaseLiabilitiesTotal	1603000	usd
CY2022Q2	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	67000	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	113000	usd
CY2022Q2	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	18000	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	22000	usd
CY2022Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	116000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	233000	usd
CY2022Q2	us-gaap	Lease Cost LeaseCost	201000	usd
	us-gaap	Lease Cost LeaseCost	368000	usd
CY2022Q2	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	11000	usd
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	13000	usd
CY2022Q2	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	67000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	85000	usd
CY2022Q2	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	295000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	1253000	usd
CY2022Q2	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y8M12D
CY2022Q2	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y8M12D
CY2022Q2	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.064
CY2022Q2	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.064
CY2022Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	151000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	302000	usd
CY2022Q2	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	453000	usd
CY2022Q2	sera	Lease Liability To Be Paid Year One LeaseLiabilityToBePaidYearOne	518000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	0	usd
CY2022Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P0Y6M
CY2022Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P0Y6M
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.045
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.045
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	302000	usd
CY2022Q2	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	253000	usd
CY2022Q2	sera	Lease Liability To Be Paid Remainder Of Fiscal Year LeaseLiabilityToBePaidRemainderOfFiscalYear	555000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	0	usd
CY2022Q2	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	518000	usd
CY2022Q2	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	462000	usd
CY2022Q2	sera	Lease Liability To Be Paid Year Two LeaseLiabilityToBePaidYearTwo	462000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	0	usd
CY2022Q2	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	191000	usd
CY2022Q2	sera	Lease Liability To Be Paid Year Three LeaseLiabilityToBePaidYearThree	191000	usd
CY2022Q2	sera	Lessee Operating Lease Liability To Be Paid Year Four And Thereafter LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter	0	usd
CY2022Q2	sera	Finance Lease Liability To Be Paid Year Four And Thereafter FinanceLeaseLiabilityToBePaidYearFourAndThereafter	0	usd
CY2022Q2	sera	Lease Liability To Be Paid Year Four And Thereafter LeaseLiabilityToBePaidYearFourAndThereafter	0	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	302000	usd
CY2022Q2	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	1424000	usd
CY2022Q2	sera	Lease Liability Payment Due LeaseLiabilityPaymentDue	1726000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	3000	usd
CY2022Q2	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	120000	usd
CY2022Q2	sera	Lease Liability Undiscounted Excess Amount LeaseLiabilityUndiscountedExcessAmount	123000	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	299000	usd
CY2022Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	1304000	usd
CY2022Q2	sera	Lease Liabilities Total LeaseLiabilitiesTotal	1603000	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	299000	usd
CY2022Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	456000	usd
CY2022Q2	sera	Lease Liability Current LeaseLiabilityCurrent	755000	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	usd
CY2022Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	848000	usd
CY2022Q2	sera	Lease Liability Noncurrent LeaseLiabilityNoncurrent	848000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P5Y
CY2021Q4	sera	Indemnification Liability IndemnificationLiability	0	usd
CY2022Q2	sera	Indemnification Liability IndemnificationLiability	0	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-6307000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-12666000	usd
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1988886	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1988886	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1890908	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1890908	shares
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.17
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.17
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-6.70
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-6.70
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	11531627	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	32112026	shares

Files In Submission

Name	View Source	Status
sera-20220630_def.xml	Edgar Link	unprocessable
0001534969-22-000123-index-headers.html	Edgar Link	pending
0001534969-22-000123-index.html	Edgar Link	pending
0001534969-22-000123.txt	Edgar Link	pending
0001534969-22-000123-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
sera-20220630.htm	Edgar Link	pending
sera-20220630.xsd	Edgar Link	pending
sera-20220630x10qxex311.htm	Edgar Link	pending
sera-20220630x10qxex312.htm	Edgar Link	pending
sera-20220630x10qxex321.htm	Edgar Link	pending
Show.js	Edgar Link	pending
sera-20220630_lab.xml	Edgar Link	unprocessable
sera-20220630_pre.xml	Edgar Link	unprocessable
sera-20220630_htm.xml	Edgar Link	completed
sera-20220630_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SERA
SERA PROGNOSTICS, INC. Stock $sera

2022 Q2 Form 10-Q Financial Statement

#000153496922000123 Filed on August 10, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SERA SERA PROGNOSTICS, INC. Stock $sera

2022 Q2 Form 10-Q Financial Statement

#000153496922000123 Filed on August 10, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SERA
SERA PROGNOSTICS, INC. Stock $sera